Energy based devices and methods for treatment of patent foramen ovale

Details for Australian Patent Application No. 2004226397 (hide)

Owner Terumo Kabushiki Kaisha

Inventors Deem, Mark E.; Francis, Dan; Gifford, Hanson S. III; Alegandro, Jose; Malecki, William; Horne, Kenneth

Agent Spruson & Ferguson

Pub. Number AU-B-2004226397

PCT Pub. Number WO2004/086950

Priority 60/458,854 27.03.03 US; 60/490,082 24.07.03 US; 60/478,035 11.06.03 US; 10/679,245 02.10.03 US

Filing date 26 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 23 April 2009

International Classifications

A61B 17/00 (2006.01) Surgery

A61B 18/14 (2006.01) Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body - Probes or electrodes therefor

A61B 17/30 (2006.01) Surgery - Surgical pincettes

A61B 17/34 (2006.01) Surgery - Trocars

A61B 19/00 (2006.01) Instruments, implements or accessories for surgery or diagnosis not covered by any of the groups , e.g. for stereotaxis, sterile operation, luxation treatment, wound edge protectors

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/086950 Priority application(s): WO2004/086950

12 June 2008 Assignment before Grant

  Cierra, Inc. The application has been assigned to Terumo Kabushiki Kaisha

23 April 2009 Application Accepted

  Published as AU-B-2004226397

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226398-Methods and apparatus for treatment of patent foramen ovale

2004226389-Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase